Aquestive Therapeutics Inc. (AQST) Tops Q2 EPS by 2c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q2 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $13.24 million versus the consensus estimate of $11.02 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• KULR Technology Group (KULR) Misses Q2 EPS by 39c
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c